🔗 Share this article

A shadow market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.

Investigational Treatment Gaining Traction Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by online personalities for its alleged weight-reducing effects. Viewers are encouraged to contact these profiles privately for source information, while also receiving discount codes.

Active Trade on Social Networks

Additionally, a robust trade exists on Telegram, where communities with thousands of participants share comparison photos, administration instructions and assertions of next-day UK delivery. Vendors promote the drug there before redirecting customers to WhatsApp for transactions.

Learning About The Experimental Drug

Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Medical Professionals Express Worries

Nevertheless, physicians and chemists have warned that the distribution of what remains an unlicensed drug in the UK is worrisome and could result in users injecting substances of unknown origin.

Some professionals said the demand for retatrutide could be connected to the rising cost of approved weight loss treatments such as Mounjaro.

Legal Position and Implementation

Selling the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.

Several content creators try to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still breach medicines, advertising, and consumer regulations, potentially leading to penalties, legal action or prison.

Platform Response and Material Removal

Based on TikTok, the platform has taken down violative material and banned associated keywords and query recommendations. The company stated it was dedicated to maintaining the service safe and allocating resources in strengthening enforcement strategies.

Digital Trading Operations

Research also found communities with up to nine thousand members marketing the experimental drug using Telegram's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately displays groups with thousands of users, populated with photos of weight loss, positive testimonials and detailed guides for mixing or administering at home.

Within minutes of joining one community, a vendor shared contact information, where most purchases take place. The seller provided an instruction manual and promised delivery within 48 hours. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None inquired about body mass, health issues or previous experience.

Product Information and Pricing

Within these communities, posts show black plastic packages with postal service labels, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at residence with sterile water, or pre-filled pens usually sold at £160 for 20mg. When questioned how long a pen should be used, sellers give contradictory answers varying between a few weeks to “depends on your body”.

Platform Moderation and Security Actions

A spokesperson for Telegram said it actively moderated dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are injecting materials they cannot confirm. Even if the science behind retatrutide is valid, these online products may not include what they claim,” said a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of an online medical service connected the surge in interest to current price rises for authorized slimming medications such as Mounjaro. “With costs rising, individuals are turning to online platforms. But counterfeit treatments are extremely risky. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she explained.

Her team has previously encountered individuals harmed by personal administration from unverified suppliers. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” stated the doctor. “These substances could be contaminated or improperly measured.”

Producer Position

A representative from the pharmaceutical company stated the substance was in third stage research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this time no one can market [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company experimental product not yet authorized … may subject users to possibly serious medical dangers”.